Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
25 /100
LOW RISK
Score updated Oct 13, 2026

PLX — Protalix BioTherapeutics, Inc. Dilution Risk Tracker

Track PLX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PLX — Get alerts when the score changes →

As of October 13, 2026, Protalix BioTherapeutics, Inc. (PLX) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Protalix BioTherapeutics, Inc. has a market capitalization of $223.99M, 80.57M shares outstanding, 100 institutional holders tracked. Stored dilution-related fields include 17.40M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway—
📊 Float Risk
15
⚠️ Warrant Exposure
70
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
📜 Warrant Exercise model 40%
• Significant warrants: 22% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track PLX — Get forecast alerts →

Market Data

Market Cap$223.99M
Shares Outstanding80.57M
Float72.73M
Cash$27.42M
Debt$912.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore25/100DilutionWatch score record
Shares Outstanding80.57MVerified float table or market cache
Public Float72.73MVerified float table or market cache
Market Cap$223.99MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants17.40MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 36.0% shares (2026Q1 vs prior)
100 institutional holders · 20.68M shares
#1 BlackRock, Inc. 3.62M shares
#2 MAK CAPITAL ONE LLC 3.54M shares
#3 Opaleye Management Inc. 2.82M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.04M
Days to Cover4.3
% of Float4.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-18
xbrl XBRL WARRANT 2025-03-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PLX Dilution Snapshot

Protalix BioTherapeutics, Inc. (PLX) has a DilutionScore of 25/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PLX's DilutionScore is currently 25/100 (Low risk), with 3 score changes tracked over 89 days. The score improved from 15/100 (Low risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202625/100LOW14 days
Aug 22 – Sep 29, 202615/100LOW39 days
Aug 14 – Aug 21, 202623/100LOW7 days
Jul 16 – Aug 13, 202618/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PLX shares outstanding have increased 0.2% from 80.42M (Mar 2026) to 80.57M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 10, 202680.57M72.73M▲ 0.92%
Apr 03, 202680.57M72.08M▲ 6.89%
Mar 22, 202680.42M67.43M▲ 0.04%
Mar 19, 202680.42M67.40M▲ 0.19%
Mar 08, 202680.42M67.28M▼ 6.46%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PLX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PLX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PLX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PLX
PLX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.